ReviewMolecules (Basel, Switzerland)2022
Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Flavonoids fromJournal of enzyme inhibition and medicinal chemistry · 2026Article
- Non-targeted metabolomics reveals tissue-specific metabolic profiling and antioxidant - related markers inFrontiers in plant science · 2026Article
- Magnesium isoglycyrrhizinate ameliorates acetaminophen-induced acute liver injury with hyperglycaemia by modulating autophagy and oxidative stress in liver-resident macrophages.Frontiers in pharmacology · 2026Article
- Preparation of nanoemulsions fromRSC advances · 2025Article
- Luteolin-7-O-glucoside from Elsholtzia ciliata extract inhibits the replication of coronavirus.PloS one · 2025Article
- A Review of Traditional Use, Constituent Analysis, Bioactivity, and Application of Volatile Oils fromCombinatorial chemistry & high throughput screening · 2025Review
- Bioactivities and Synergistic Effect ofMolecules (Basel, Switzerland) · 2024Article
- New Light on Plants and Their Chemical Compounds Used in Polish Folk Medicine to Treat Urinary Diseases.Pharmaceuticals (Basel, Switzerland) · 2024Review
- Article
- Acute and Sub-Chronic Intraperitoneal Toxicity Studies of thePharmaceutics · 2023Article
- Evaluation of the antibacterial activity ofFrontiers in microbiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
In this paper, the confusion of the sources of medicinal materials was briefly expounded, and the differences among the varieties were pointed out. At the same time, the chemical components and pharmacological properties of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.